Brigita Budiene1, Rasa Liutkeviciene1,2, Olivija Gustiene3, Rasa Ugenskiene4, Danguole Laukaitiene4, Aiste Savukaityte4, Alvita Vilkeviciute2, Rasa Steponaviciute5, Aurelija Rocyte5, Dalia Zaliuniene1. 1. a Department of Ophthalmology , Lithuanian University of Health Sciences , Kaunas , Lithuania. 2. b Department of Cardiology , Lithuanian University of Health Sciences , Kaunas , Lithuania. 3. c Oncology Research Laboratory, Institute of Oncology , Lithuanian University of Health Sciences , Kaunas , Lithuania. 4. d Neuroscience Institute , Lithuanian University of Health Sciences , Kaunas , Lithuania. 5. e Department of Laboratory Medicine , Laboratory of Clinical Chemistry and Genetics, Lithuanian University of Health Sciences , Kaunas , Lithuania.
Abstract
PURPOSE: To assess the impact of matrix metalloproteinase (MMP)1-1607 1G/2G (rs1799750), MMP7-181 A/G (rs11568818) single-nucleotide polymorphism and systemic cytokins interleukin-1 beta (IL-1β), IL-6 levels on the development of exudative age-related macular degeneration (eAMD) Methodology: The study group comprised 282 patients with eAMD, and the control group enrolled 379 randomly selected persons. The genotyping of MMP1-1607 (rs1799750) and MMP7-181 (rs11568818) was performed by using the polymerase chain reaction-based restriction fragment length polymorphism method. To determine IL-1β and IL-6 serum levels, the immunoenzymatic method with monoclonal antibodies coated plates was performed. RESULTS: MMP1 rs1799750 1G/2G genotype was more frequently found in the development of eAMD. It was associated with a 4.3-fold increased risk for eAMD under the codominant model and a 4.9-fold increased risk for eAMD under the overdominant model. The effect was more pronounced at the age of less than 65 years. IL-1β concentration was significantly higher for MMP1 rs1799750 1G/1G genotype and MMP7 rs11568818 A/G genotype in eAMD patients compared with control group subjects. CONCLUSIONS: MMP1 rs1799750 1G/2G genotype was found to play a significant role in the development of eAMD at the age of less than 65 years. IL-1β concentration was significantly higher in eAMD patients for MMP1 rs1799750 1G/1G genotype and MMP7 rs11568818 A/G genotype compared with control group subjects.
PURPOSE: To assess the impact of matrix metalloproteinase (MMP)1-1607 1G/2G (rs1799750), MMP7-181 A/G (rs11568818) single-nucleotide polymorphism and systemic cytokins interleukin-1 beta (IL-1β), IL-6 levels on the development of exudative age-related macular degeneration (eAMD) Methodology: The study group comprised 282 patients with eAMD, and the control group enrolled 379 randomly selected persons. The genotyping of MMP1-1607 (rs1799750) and MMP7-181 (rs11568818) was performed by using the polymerase chain reaction-based restriction fragment length polymorphism method. To determine IL-1β and IL-6 serum levels, the immunoenzymatic method with monoclonal antibodies coated plates was performed. RESULTS:MMP1rs1799750 1G/2G genotype was more frequently found in the development of eAMD. It was associated with a 4.3-fold increased risk for eAMD under the codominant model and a 4.9-fold increased risk for eAMD under the overdominant model. The effect was more pronounced at the age of less than 65 years. IL-1β concentration was significantly higher for MMP1rs1799750 1G/1G genotype and MMP7rs11568818 A/G genotype in eAMD patients compared with control group subjects. CONCLUSIONS:MMP1rs1799750 1G/2G genotype was found to play a significant role in the development of eAMD at the age of less than 65 years. IL-1β concentration was significantly higher in eAMD patients for MMP1rs1799750 1G/1G genotype and MMP7rs11568818 A/G genotype compared with control group subjects.
Authors: Luping Wang; Sarah Schmidt; Petra P Larsen; Johanna H Meyer; William R Roush; Eicke Latz; Frank G Holz; Tim U Krohne Journal: J Mol Med (Berl) Date: 2019-02-10 Impact factor: 4.599
Authors: Jacob K Sterling; Bailey Baumann; Sierra Foshe; Andrew Voigt; Samyuktha Guttha; Ahab Alnemri; Sam J McCright; Mingyao Li; Randy J Zauhar; Sandra R Montezuma; Rebecca J Kapphahn; Venkata R M Chavali; David A Hill; Deborah A Ferrington; Dwight Stambolian; Robert F Mullins; David Merrick; Joshua L Dunaief Journal: Cell Rep Date: 2022-06-14 Impact factor: 9.995
Authors: Luis García-Onrubia; Fco Javier Valentín-Bravo; Rosa M Coco-Martin; Rogelio González-Sarmiento; J Carlos Pastor; Ricardo Usategui-Martín; Salvador Pastor-Idoate Journal: Int J Mol Sci Date: 2020-08-18 Impact factor: 5.923
Authors: Khanh V Do; Marie-Audrey I Kautzmann; Bokkyoo Jun; William C Gordon; Robert Nshimiyimana; Rong Yang; Nicos A Petasis; Nicolas G Bazan Journal: Proc Natl Acad Sci U S A Date: 2019-11-11 Impact factor: 11.205